Huntsman Cancer Institute at the University of Utah signed a contract with Mevion Medical Systems for a second MEVION S250i Proton Therapy System, doubling treatment capacity and broadening access to patients with a wide range of cancers, including pediatric, head and neck, and breast cancers.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe